Assessing health-related quality of life in generalized anxiety disorder using the Quality of Life Enjoyment and Satisfaction Questionnaire

International Clinical Psychopharmacology

Volumn 24, Issue 6, 2009, Pages 289-295

  Wyrwich, Kathleen ^d   Harnam, Neesha ^d   Revicki, Dennis A ^d   Locklear, Julie C ^a   Svedsäter, Henrik ^b   Endicott, Jean ^c  

^a ASTRAZENECA   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Generalized anxiety disorder; Minimal important difference; Q LES Q(SF); Quetiapine extended release; Reliability; Responsiveness; Validity

Indexed keywords

QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE;

ADULT; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND SATISFACTION QUESTIONNAIRE; QUESTIONNAIRE; RELIABILITY; REMISSION; REVIEW; SCORING SYSTEM; VALIDITY; ADOLESCENT; AGED; ANXIETY DISORDER; ARTICLE; DELAYED RELEASE FORMULATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; DELAYED-ACTION PREPARATIONS; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS;

EID: 73949106511     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32832d6bf4     Document Type: Review

References (38)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association.
2. Barger SD, Sydeman SJ (2005). Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? J Affect Disord 88:87-91.
3. Bruce SE, Machan JT, Dyck I, Keller MB (2001). Infrequency of 'pure' GAD: impact of psychiatric comorbidity on clinical course. Depress Anxiety 14:219-225.
4. Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213.
5. Chouinard G, Ahokas A, Bandelow B, Bobes J, Eggens I, Liu S, Brecher M (2008). Extended release quetiapine fumarate (quetiapine XR) once-daily monotherapy in generalized anxiety disorder (GAD). Presented at The Annual Meeting of the Anxiety Disorders Association of America; 6-9 March 2008, Savannah, Georgia USA.
6. Cohen J (1977.) Statistical power analysis for the behavioral sciences, rev edition. New York: Academic Press.
7. Cronbach LJ (1951). Coefficient alpha and the internal structure of tests. Psychometrika 16:297-334.
8. Demyttenaere K, Andersen HF, Reines EH (2008). Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. Int Clin Psychopharmacol 23:276-286.
9. Dott SG, Walling DP, Bishop SL, Buey JE, Folkes CC (1996). The efficacy of short-term treatment for improving the quality of life: a pilot study. J Nerv Ment Dis 184:507-509. (Pubitemid 26285733)
10. Endicott J, Nee J, Harrison W, Blumenthal R (1993). Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull 29:321-326. (Pubitemid 23311543)
11. Endicott J, Nee J, Yang R, Wohlberg C (2006). Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q): reliability and validity. J Am Acad Child Adolesc Psychiatry 45:401-407. (Pubitemid 43675544)
12. Endicott J, Russell JM, Raskin J, Detke MJ, Erickson J, Ball SG, et al. (2007a). Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies. J Clin Psychiatry 68:518-524.
13. Endicott J, Rajagopalan K, Minkwitz M, Macfadden W, BOLDER Study Group (2007b). A randomized, double-blind, placebo-controlled study of quetiapine In the treatment of bipolar I and II depression: improvements in quality of life. Int Clin Psychopharmacol 22:29-37. (Pubitemid 44950765)
14. ESEMeD/MHEDEA 2000 Investigators (2004). Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 109 (Suppl 1):21-27.
15. Eton DT, Cella D, Bacik J, Motzer RJ (2006). A brief symptom index for advanced renal cell carcinoma. Health Qual Life Outcomes 4:68. (Pubitemid 44649669)
16. Faravell C, Guerrini Degl'Innocenti B, Giardinelli L (1989). Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand 79:308-312.
17. Grant BF, Hasin DS, Stinson FS, Dawson DA, June RW, Goldstein RB, et al. (2005). Prevalence, correlates, comorbidity, and comparative disability of DSM IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 35:1747-1759.
18. Hays RD, Revicki D (2005). Reliability and validity (including responsiveness). In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. Second edition. New York: Oxford University Press.
19. Hays RD, Woolley JM (2000). The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 18:419-423.
20. Henning ER, Turk CL, Mennin DS, Fresco DM, Heimberg RG (2007). Impairment and quality of life in individuals with generalized anxiety disorder. Depress Anxiety 24:342-349. (Pubitemid 47403484)
21. Hoyer J, Becker ES, Margraf J (2002). Generalized anxiety disorder and clinical worry episodes in young women. Psychol Med 32:1227-1237. (Pubitemid 35243980)
22. Joyce M, Khan A, Atkinson S, Eggens I, Baldytcheva I, Brecher M (2008). Efficacy and safety of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder (GAD) [poster]. Washington, DC, USA. Presented at the Annual Meeting of the American Psychiatric Association.
23. Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Lowe B (2007). Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 146:317-325. (Pubitemid 351650592)
24. Merideth C, Cutler A, Neijber A, She F, Eriksson H (2008). Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in the treatment of generalised anxiety disorder. Eur Neuropsychopharmacol 18 (Suppl 4):S499.
25. Mick E, Faraone SV, Spencer T, Zhang HF, Biederman J (2008). Assessing the validity of the Quality of Life Enjoyment and Satisfaction Questionnaire Short Form in adults with ADHD. J Atten Disord 11:504-509.
26. Newnham EA, Harwood KE, Page AC (2007). Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. J Affect Disord 98:91-97.
27. Norman GR, Sloan JA, Wyrwich KW (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582-592.
28. Olfson M, Fireman B, Weissman MM, Leon AC, Sheehan DV, Kathol RG, et al. (1997). Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry 154:1734-1740.
29. Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, et al. (2008). Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetlne treatment. J Psychiatr Res 42:1042-1049. [Epub ahead of print]
30. Rapaport MH, Clary C, Fayyad R, Endicott J (2005). Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162:11 71-11 78.
31. Revicki DA, Brandenburg N, Matza L, Hornbrook MC, Feeny D (2008a). Health-related quality of life and utilities in primary care patients with generalized anxiety disorder. Qual Life Res 17:1285-1 294. [Epub ahead of print]
32. Revicki D, Hays RD, Cella D, Sloan J (2008b). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61:102-109.
33. Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J (2005). Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res 14:1693-1703. (Pubitemid 40978478)
34. Rossi A, Rucci P, Mauri M, Maina G, Pieraccini F, Pallanti S, et al. (2005). Validity and reliability of the Italian version of the Quality of Life Enjoyment and Satisfaction Questionnaire. Qual Life Res 14:2323-2328.
35. Schonfeld WH, Verboncoeur CJ, Fifer SK, Lipschutz RC, Lubeck DP, Buesching DP (1997). The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Affect Disord 43:105-119.
36. Schechter D, Endicott J, Nee J (2007). Quality of life of 'normal' controls: association with lifetime history of mental illness. Psychiatry Res 152:45-54.
37. Stein MB, Heimberg RG (2004). Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample. J Affect Disord 79:161-166. http://www.fda.gov/ohrms/dockets/ dockets/06d0044/1.htm. [Accessed October 2008]. (Pubitemid 38340539)
38. Wetherell JL, Thorp SR, Patterson TL, Golshan S, Jeste DV, Gatz M (2004). Quality of life in geriatric generalized anxiety disorder: a preliminary investigation. J Psychiatr Res 38:305-312. (Pubitemid 38299168)